The D-1-like, D-2-like, alpha(1) and alpha(2) in vitro activities of 2-aminotetraline congeners are reported. Z1046 was selected and the antihypertensive activity in rat and dog was evaluated both by intravenous and oral routes. Copyright (C) 1996 Elsevier Science Ltd
Compounds of formula
(wherein R, R₁, R₂ and R₃ have the meanings reported in the specification), their preparation and the compositions for pharmaceutical use containing them as active ingredient are described. The compounds of formula I have dopaminergic vasodilator activity and they may be used in pharmaceutical field.
式化合物
(其中 R、R₁、R₂ 和 R₃ 的含义见说明书)、其制备方法以及含有它们作为活性成分的药用组合物。式 I 的化合物具有多巴胺能血管扩张活性,可用于制药领域。
JPH02743A
申请人:——
公开号:JPH02743A
公开(公告)日:1990-01-05
US5093355A
申请人:——
公开号:US5093355A
公开(公告)日:1992-03-03
Pyman, Journal of the Chemical Society, 1910, vol. 97, p. 275
The D-1-like, D-2-like, alpha(1) and alpha(2) in vitro activities of 2-aminotetraline congeners are reported. Z1046 was selected and the antihypertensive activity in rat and dog was evaluated both by intravenous and oral routes. Copyright (C) 1996 Elsevier Science Ltd